PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Clinical trial NCT06186609 · UNKNOWN

Trial details

NCT number: NCT06186609
Sponsor: Affiliated Hospital of Nantong University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2023-07-01
Primary completion: 2025-06-10
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.